Certolizumab pegol Completed Phase 1 Trials for Bioavailability Study on Healthy Volunteers Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT00813774Bio-availability Comparison of Three Formulations of Certolizumab Pegol in Healthy Volunteers